CareDx, Inc (CDNA) Stock | CDNA Stock Price & Analysis

Feed

CDNA

CareDx, Inc CDNA · NASDAQ

$78.56 +2.92% (+$2.23)

Summary

47 / 100 · Bulios Score

Valuation 6Growth 37Profitability 63Quality 55Debt 100Stability 20

What speaks for it

Out of every 100 USD of revenue, 26 USD is left as net profit.
It holds more cash than debt: $250.5M against $20.3M.
Analysts expect revenue to grow by 38% this fiscal year.

What to watch

The share price is above the Bulios Fair Price.
Revenue growth is slowing: 5.7% a year over the last 3 years against 15% over 5 years.
It earns only 0.9 USD a year on every 100 USD of invested capital.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Is it expensive?

Looks expensive

Bulios Fair Price

Current price $78.56

P/E today 32.1

Medical - Diagnostics & Research industry median

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 32.1 USD for 1 USD of yearly profit.

Valuation in detail

Is it growing?

Slowly

Revenue (USD)

296M

322M

280M

334M

380M

525M

572M

2021202220232024202520262027

Diluted EPS (USD)

-$0.59

-$1.44

-$3.54

$0.93

-$0.40

$1.78

$1.58

2021202220232024202520262027

Analyst estimate

Revenue grew by 15% a year over 5 years. Over the last 3 years it grew by 5.7% a year. For the next fiscal year analysts expect revenue to grow by 38%.

Growth in detail

Does it make money?

Reasonably

Where 100 USD of revenue goes

Cost of sales 21 USD
Research and development 17 USD
Sales and administration 61 USD
Taxes and other -25 USD
Net profit 26 USD

Net profit, industry median (Medical - Diagnostics & Research) 9.8 USD

Out of every 100 USD of revenue, 26 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Cash and short-term investments $250.5M

Debt $20.3M

Free cash flow over 12 months $60.1M

It could repay all its debt from a single year of free cash flow. It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Buy 11
Hold 3
Sell 0

Today's price within the analysts' price targets

Today's price $78.56 Average target $75.25

$46 $99

The average target of $75.25 is 4.2% below today's price. 79% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

Service 85%
Product 15%

By region

UNITED STATES 95%
Non-US 5.2%

Service brings in 85% of revenue.

Segments in detail